Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils

Elise Glattard1, Ingeborg D Welters, Thomas Lavaux

  • 1Inserm, U575, Physiopathologie du Système Nerveux and Nociception and Pain Department, Institut des Neurosciences Cellulaires et Intégratives, Centre National de la Recherche Scientifique, Université de Strasbourg, Strasbourg, France.

Plos One
|January 26, 2010
PubMed
Abstract

Insights

Endogenous morphine is released by human neutrophils during sepsis, increasing in patient serum. This morphine can inhibit inflammatory responses, suggesting a role in infection.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Mammalian cells, including human neutrophils, synthesize and release endogenous morphine.
  • The precise role of endogenous morphine in inflammatory processes, particularly during infection, remains largely unknown.
  • This study investigates the potential release of morphine during sepsis and its presence in patient serum.

Purpose of the Study:

  • To investigate the presence and subcellular localization of endogenous morphine in human neutrophils.
  • To determine if morphine is released by neutrophils upon activation and if its levels are elevated in septic patients.
  • To explore the functional role of endogenous morphine in modulating inflammatory responses during sepsis.

Main Methods:

  • Utilized ELISA, mass spectrometry, and laser confocal microscopy to detect and localize endogenous morphine in neutrophils.
  • Activated neutrophils with Interleukin-8 (IL-8) or lipopolysaccharide (LPS) to assess morphine secretion.
  • Measured serum morphine concentrations in septic patients and healthy controls, confirming identity via mass spectrometry.

Main Results:

  • Confirmed morphine presence in human neutrophils, localized within secondary granules.
  • Demonstrated significant morphine release from neutrophils activated by LPS or IL-8 in the presence of calcium.
  • Observed elevated serum morphine levels in patients with sepsis, severe sepsis, and septic shock compared to controls.

Conclusions:

  • Morphine concentrations are significantly increased in the serum of patients with systemic infections like sepsis.
  • Neutrophils contribute to morphine secretion during sepsis.
  • Physiological concentrations of morphine inhibit LPS-induced IL-8 release from neutrophils, suggesting an anti-inflammatory role.

Related Concept Videos

Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Inflammation01:38

Inflammation

Overview